N#Cc1c(N2C(=O)[C@H]3[C@H]4C[C@@H]([C@H]3C2=O)[C@@H]2C(c3ccc(Cl)cc3)=NO[C@H]42)sc2c1CCCC2
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?